Showing 2361-2380 of 7110 for: Cochrane Systematic Reviews Back
- Fluoride for treating postmenopausal osteoporosis
Cochrane Systematic Reviews, 24-May-2010
Osteoporosis is a condition that results in an increased risk of fractures due to the reduction of bone volume, which is caused by an imbalance between bone formation and bone resorption. Because of this property, fluoride has been used for over 30 years
- Fluoride gels for preventing dental caries in children and adolescents
Cochrane Systematic Reviews, 10-Jun-2015
Topically applied fluoride gels have been widely used as a caries-preventive intervention in dental surgeries and school-based programmes for over three decades. This updates the Cochrane review of fluoride gels for preventing dental caries in children an
- Fluoride mouthrinses for preventing dental caries in children and adolescents
Cochrane Systematic Reviews, 26-Aug-2008
Fluoride mouthrinses have been used extensively as a caries-preventive intervention in school-based programmes and individually at home.
- Fluoride supplements (tablets, drops, lozenges or chewing gums) for preventing dental caries in children
Cochrane Systematic Reviews, 9-Nov-2011
Dietary fluoride supplements were first introduced to provide systemic fluoride in areas where water fluoridation is not available. Since 1990, the use of fluoride supplements in caries prevention has been re-evaluated in several countries.
- Fluoride toothpastes for preventing dental caries in children and adolescents
Cochrane Systematic Reviews, 26-Aug-2008
Fluoride toothpastes have been widely used for over 3 decades and remain a benchmark intervention for the prevention of dental caries.
- Fluoride toothpastes of different concentrations for preventing dental caries in children and adolescents
Cochrane Systematic Reviews, 19-Jan-2010
Caries (dental decay) is a disease of the hard tissues of the teeth caused by an imbalance, over time, in the interactions between cariogenic bacteria in dental plaque and fermentable carbohydrates (mainly sugars). The use of fluoride toothpaste is the pr
- Fluoride varnishes for preventing dental caries in children and adolescents
Cochrane Systematic Reviews, 18-Feb-2014
Topically-applied fluoride varnishes have been used extensively as an operator-applied caries-preventive intervention for over three decades. This review updates the first Cochrane review of fluoride varnishes for preventing dental caries in children and
- Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Cochrane Systematic Reviews, 4-Dec-2013
Demineralised white lesions (DWLs) can appear on teeth during fixed brace treatment because of early decay around the brackets that attach the braces to the teeth. Fluoride is effective in reducing decay in susceptible individuals in the general populatio
- Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
Cochrane Systematic Reviews, 9-Nov-2021
Rhabdomyosarcoma (RMS) is the most common paediatric soft-tissue sarcoma and can emerge throughout the whole body. For patients with newly diagnosed RMS, prognosis for survival depends on multiple factors such as histology, tumour site, and extent of the
- Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer
Cochrane Systematic Reviews, 9-Mar-2011
Although locoregional treatments such as hepatic arterial infusion (HAI) claim the advantage of delivering higher doses of anticancer agents directly into the metastatic organ as compared to systemic chemotherapy (SCT), the benefit in terms of overall sur
- Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)
Cochrane Systematic Reviews, 30-May-2013
Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs. However, use of fluoroquinolones could shorten the length of treatment and improve
- Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)
Cochrane Systematic Reviews, 16-Nov-2011
Typhoid and paratyphoid are febrile illnesses, due to a bacterial infection, which remain common in many low- and middle-income countries. The World Health Organization (WHO) currently recommends the fluoroquinolone antibiotics in areas with known resista
- Fluoxetine for adults who are overweight or obese
Cochrane Systematic Reviews, 15-Oct-2019
Fluoxetine is a serotonin reuptake inhibitor indicated for major depression. It is also thought to affect weight control: this seems to happen through appetite changes resulting in decreased food intake and normalisation of unusual eating behaviours. Howe
- Fluoxetine versus other types of pharmacotherapy for depression
Cochrane Systematic Reviews, 16-Jul-2013
Depression is common in primary care and is associated with marked personal, social and economic morbidity, thus creating significant demands on service providers. The antidepressant fluoxetine has been studied in many randomised controlled trials (RCTs)
- Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders
Cochrane Systematic Reviews, 23-May-2014
Long-acting depot injections of drugs such as flupenthixol decanoate are extensively used as a means of long-term maintenance treatment for schizophrenia.
- Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
Cochrane Systematic Reviews, 29-Jul-2014
Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic drugs, however, low-potency antipsychotic drugs are sometimes perceived as less efficacious than high-po
- Flupenthixol versus placebo for schizophrenia
Cochrane Systematic Reviews, 11-Sep-2012
Flupenthixol, first made available in the UK in 1965, has been used as a treatment for schizophrenia for decades.
- Fluphenazine (oral) versus placebo for schizophrenia
Cochrane Systematic Reviews, 12-Jun-2018
Fluphenazine is one of the first drugs to be classed as an 'antipsychotic' and has been widely available for five decades.
- Fluphenazine decanoate (depot) and enanthate for schizophrenia
Cochrane Systematic Reviews, 25-Feb-2016
Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance. The benefits gained by long-acting preparations, however, may be offset by a higher incidence of adverse effects.
- Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Cochrane Systematic Reviews, 28-Jul-2014
Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however, low-potency antipsychotic drugs are often perceived as less efficacious th
